Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)

NCT07203677 · clinicaltrials.gov ↗

COMPLETED

Status

49065

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes Mellitus
Atherosclerotic Cardiovascular Disease

Interventions

DRUG: Initiation of tirzepatide
DRUG: Initiation of sitagliptin

Sponsor

Brigham and Women's Hospital